Abstract Number: 1146 • ACR/ARHP Annual Meeting 2018
The Association of Raas Inhibitor Use with Osteoporosis. Findings from the Women’s Health Initiative
Background/Purpose: Experimental studies have implicated a role for the Renin Angiotensin Aldosterone System (RAAS) in osteoporosis. However, the relationship of pharmacological inhibition of the RAAS…Abstract Number: 468 • ACR/ARHP Annual Meeting 2016
Angiotensin II Exacerbates Bone Destruction in TNF-Transgenic Arthritis Mice
Background/Purpose: Angiotensin II (Ang II) is known to function on various organs including kidneys, adrenal glands as well as the nervous and cardiovascular systems. In…Abstract Number: 1712 • ACR/ARHP Annual Meeting 2014
Monocytic Angiotensin and Endothelin Receptor Imbalance Determines Secretion of the Profibrotic Chemokine Ligand CCL18
Background/Purpose Circulating monocytes are progrenitor of extra-cellular matrix producing cells involved in fibrosis and show highest expression of angiotensin II (ATR) and endothelin receptors (ETR)…Abstract Number: 2230 • ACR/ARHP Annual Meeting 2013
Specific Angiotensin Type II Receptor Stimulation Attenuates Collagen-Induced Arthritis Via Enhancement Of FoxP3 Regulatory T Cells
Background/Purpose: The renin-angiotensin system (RAS) is known to play an important role in inflammation, fibrosis, and end-organ damage. Moreover, AT2R signalling exerts anti-inflammatory and anti-apoptotic…Abstract Number: 1491 • ACR/ARHP Annual Meeting 2012
Systemic Sclerosis – Effects of Agonistic Autoantibodies Directed Against the Angiotensin Receptor Type 1 and the Endothelin Receptor Type A On Effector Cells
Background/Purpose: Autoimmunity, vasculopathy and fibrosis are features of systemic sclerosis (SSc). The functional link between these three pathophysiological components is still missing. Research suggests an…
ACR Meeting Abstracts